BMS-247550 in Treating Patients With Metastatic Colorectal Cancer

NCT00033306 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: ixabepilone
DRUG: Fluoropyrimidine
DRUG: Irinotecan

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]